Status:
COMPLETED
Enhancing Consent for Alzheimer's Research
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for patients with mild-to-moderate Alzheimer disease, and to identify factors and patient characteristics that pr...
Detailed Description
Alzheimer disease can impair the capacity of patients to give informed consent for research participation. Studies of informed consent involving other patient populations suggest better understanding ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of mild to moderate possible or probable AD or demographically comparable healthy comparison subjects
- Fluency in English
- 50 yrs and older
- Informed written consent (or written assent with consent from legally authorized representative)
Exclusion
- Diagnosis of Lewy Body Dementia or Mild Cognitive Impairment
- MMSE less than 15
- Physical or medical conditions that preclude participants from completing tasks
- Healthy comparison volunteers if they have a known neurologic or psychiatric condition that could impair neurocognitive functioning
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT00453544
Start Date
April 1 2006
End Date
September 1 2012
Last Update
June 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Veterans Affairs San Diego Healthcare System
San Diego, California, United States, 92161